ADCs & Engineered Antibodies Beacon
Make Faster, Better Drug Development Decisions
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies combined with the most accurate and comprehensive data, provide our customers with unparalleled visibility of the drug and trial landscape.
Beacon
Beacon
Beacon
Beacon
ADC Landscape Review
Download this critical review to receive an in-depth analysis of the ADC landscape, and for the first time, valuable commercial intelligence from our new Deals and Companies data expansion. Put yourself at the forefront of innovation with unparalleled insights into the dynamic and fast-paced world of ADC development with Beacon ADC.
Bispecific Landscape Review
The 2023 Bispecific Landscape Review delves into the intricate details of bispecific development, from mechanisms of action to scaffold formats, it offers insights into the strategies shaping the future of bispecific therapeutics.
Checkpoint Landscape Review
Our checkpoint experts have curated a comprehensive review of the 2023 landscape, providing an analysis of the emerging trends, strategic opportunities, and the challenges faced by developers.
Cytokine Landscape Review
Our review offers a thorough examination of preclinical data, cytokine engineering strategies and top targets. Plus, uncover the reasons behind the 10 discontinuations observed in 2023.
ADCs & Engineered Antibodies Beacon Team
ADCs & Engineered Antibodies Products by Type
Premium Insight and Meaningful Connections for Biopharma
Expert-driven, Life Science Market Intelligence Solution
CONTACT US
Get in touch
We speak to hundreds of biopharmaceutical experts from industry and academia every day. We would love for you to be one of them. Contact us to discover how our events can accelerate your drug development.
Standard Form - ADCs & Engineered Antibodies
"*" indicates required fields